Page 191

192. Wall PD, Melzack R. 1994. Textbook of Pain. Edinburgh: Churchill Livingstone.

193. Walters TR. 1996. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: A review of safety, efficacy, dose response, and dosing studies. Survey of Ophthalmology 41(Suppl. 1):S19-S26.

194. Wang ZM, Visser M, Ma R, Baumgartner RN, Kotler DP, Gallagher D, Heymsfield SB. 1996. Skeletal muscle mass: Validation of neutron activation and dual energy X-ray absorptiometry methods by computerized tomography. Journal of Applied Physiology 80:824-831.

195. Whitney EN, Cataldo CB, Rolfes SR. 1994. Understanditng Normal and Clinical Nutrition. 4th Edition. Minneapolis, MN: West Publishing Co.

196. Wood. 1998. HIV-protease inhibitors. Drug Therapy 338:1281-1292.

197. Yoles E, Belkin M, Schwartz M. 1996. HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy. Journal of Neurotrauma 13:49-57.

198. Zimmer L, Morgan JP. 1997. Marijuana Myths, Marijuana Facts. New York: The Lindesmith Center.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement